{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:28:06Z","timestamp":1788499686121,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004722","name":"Stiftelsen Lars Hiertas Minne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is a clinical need for conceptually new treatments that target the excessive activation of inflammatory pathways during systemic infection. Thrombin-derived C-terminal peptides (TCPs) are endogenous anti-infective immunomodulators interfering with CD14-mediated TLR-dependent immune responses. Here we describe the development of a peptide-based compound for systemic use, sHVF18, expressing the evolutionarily conserved innate structural fold of natural TCPs. Using a combination of structure- and in silico-based design, nuclear magnetic resonance spectroscopy, biophysics, mass spectrometry, cellular, and in vivo studies, we here elucidate the structure, CD14 interactions, protease stability, transcriptome profiling, and therapeutic efficacy of sHVF18. The designed peptide displays a conformationally stabilized, protease resistant active innate fold and targets the LPS-binding groove of CD14. In vivo, it shows therapeutic efficacy in experimental models of endotoxin shock in mice and pigs and increases survival in mouse models of systemic polymicrobial infection. The results provide a drug class based on Nature\u00b4s own anti-infective principles.<\/jats:p>","DOI":"10.1038\/s41467-023-41702-y","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T13:01:51Z","timestamp":1695992511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-2900","authenticated-orcid":false,"given":"Ganna","family":"Petruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-7234","authenticated-orcid":false,"given":"Manoj","family":"Puthia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdaus","family":"Samsudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7554-3945","authenticated-orcid":false,"given":"Jitka","family":"Petrlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-6130","authenticated-orcid":false,"given":"Franziska","family":"Olm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Mittendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1253-4969","authenticated-orcid":false,"given":"Snejana","family":"Hyll\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Edstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Charlotte","family":"Str\u00f6mdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7694-285X","authenticated-orcid":false,"given":"Simon","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-9040","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Walse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-5279","authenticated-orcid":false,"given":"Sven","family":"Kjellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2900-098X","authenticated-orcid":false,"given":"Peter J.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lindstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-3141","authenticated-orcid":false,"given":"Artur","family":"Schmidtchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"41702_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499\u2013511 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"41702_CR2","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R. S. et al. Sepsis and septic shock. Nat. Rev. Dis. Prim. 2, 16045 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"41702_CR3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood-2008-07-019307","volume":"113","author":"BA Beutler","year":"2009","unstructured":"Beutler, B. A. TLRs and innate immunity. Blood 113, 1399\u20131407 (2009).","journal-title":"Blood"},{"key":"41702_CR4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000316286","volume":"2","author":"HK de Jong","year":"2010","unstructured":"de Jong, H. K., van der Poll, T. & Wiersinga, W. J. The systemic pro-inflammatory response in sepsis. J. Innate Immun. 2, 422\u2013430 (2010).","journal-title":"J. Innate Immun."},{"key":"41702_CR5","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"41702_CR6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nri2402","volume":"8","author":"D Rittirsch","year":"2008","unstructured":"Rittirsch, D., Flierl, M. A. & Ward, P. A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776\u2013787 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"41702_CR7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"41702_CR8","doi-asserted-by":"crossref","first-page":"154096","DOI":"10.1016\/j.jcrc.2022.154096","volume":"71","author":"M van den Berg","year":"2022","unstructured":"van den Berg, M., van Beuningen, F. E., Ter Maaten, J. C. & Bouma, H. R. Hospital-related costs of sepsis around the world: A systematic review exploring the economic burden of sepsis. J. Crit. Care 71, 154096 (2022).","journal-title":"J. Crit. Care"},{"key":"41702_CR9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 395, 200\u2013211 (2020).","journal-title":"Lancet"},{"key":"41702_CR10","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll, T., Shankar-Hari, M. & Wiersinga, W. J. The immunology of sepsis. Immunity 54, 2450\u20132464 (2021).","journal-title":"Immunity"},{"key":"41702_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","volume":"20","author":"JC Marshall","year":"2014","unstructured":"Marshall, J. C. Why have clinical trials in sepsis failed? Trends Mol. Med. 20, 195\u2013203 (2014).","journal-title":"Trends Mol. Med."},{"key":"41702_CR12","doi-asserted-by":"publisher","unstructured":"Mart\u00ed\u2010Carvajal, A. J., Salanti, G. & Cardona\u2010Zorrilla, A. F. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst. Rev. CD004388 https:\/\/doi.org\/10.1002\/14651858.CD004388.pub3 (2008). Accessed 20 Sept 2023.","DOI":"10.1002\/14651858.CD004388.pub3"},{"key":"41702_CR13","first-page":"2439","volume":"306","author":"M Mitka","year":"2011","unstructured":"Mitka, M. Drug for severe sepsis is withdrawn from market, fails to reduce mortality. JAMA 306, 2439\u20132440 (2011).","journal-title":"JAMA"},{"key":"41702_CR14","doi-asserted-by":"crossref","first-page":"e1000857","DOI":"10.1371\/journal.ppat.1000857","volume":"6","author":"P Papareddy","year":"2010","unstructured":"Papareddy, P. et al. Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog. 6, e1000857 (2010).","journal-title":"PLoS Pathog."},{"key":"41702_CR15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05242-0","volume":"9","author":"R Saravanan","year":"2018","unstructured":"Saravanan, R. et al. Structural basis for endotoxin neutralisation and anti-inflammatory activity of thrombin-derived C-terminal peptides. Nat. Commun. 9, 2762 (2018).","journal-title":"Nat. Commun."},{"key":"41702_CR16","volume":"7","author":"MJ van der Plas","year":"2016","unstructured":"van der Plas, M. J. et al. Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses. Nat. Commun. 7, 11567 (2016).","journal-title":"Nat. Commun."},{"key":"41702_CR17","doi-asserted-by":"crossref","first-page":"e51313","DOI":"10.1371\/journal.pone.0051313","volume":"7","author":"M Kalle","year":"2012","unstructured":"Kalle, M. et al. Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis. PLoS One 7, e51313 (2012).","journal-title":"PLoS One"},{"key":"41702_CR18","volume":"7","author":"CH Lim","year":"2017","unstructured":"Lim, C. H. et al. Thrombin-derived host defence peptide modulates neutrophil rolling and migration in vitro and functional response in vivo. Sci. Rep. 7, 11201 (2017).","journal-title":"Sci. Rep."},{"key":"41702_CR19","doi-asserted-by":"crossref","first-page":"eaax6601","DOI":"10.1126\/scitranslmed.aax6601","volume":"12","author":"M Puthia","year":"2020","unstructured":"Puthia, M. et al. A dual-action peptide-containing hydrogel targets wound infection and inflammation. Sci. Transl. Med. 12, eaax6601 (2020).","journal-title":"Sci. Transl. Med."},{"key":"41702_CR20","doi-asserted-by":"crossref","unstructured":"Stromdahl, A. C. et al. Peptide-coated polyurethane material reduces wound infection and inflammation. Acta Biomater. 128, 314\u2013331 (2021).","DOI":"10.1016\/j.actbio.2021.04.045"},{"key":"41702_CR21","doi-asserted-by":"crossref","first-page":"e064866","DOI":"10.1136\/bmjopen-2022-064866","volume":"13","author":"S Lundgren","year":"2023","unstructured":"Lundgren, S. et al. Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. BMJ Open 13, e064866 (2023).","journal-title":"BMJ Open"},{"key":"41702_CR22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13197-3","volume":"7","author":"R Saravanan","year":"2017","unstructured":"Saravanan, R. et al. Proteolytic signatures define unique thrombin-derived peptides present in human wound fluid in vivo. Sci. Rep. 7, 13136 (2017).","journal-title":"Sci. Rep."},{"key":"41702_CR23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41587-019-0222-z","volume":"37","author":"R Mourtada","year":"2019","unstructured":"Mourtada, R. et al. Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice. Nat. Biotechnol. 37, 1186\u20131197 (2019).","journal-title":"Nat. Biotechnol."},{"key":"41702_CR24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nprot.2011.324","volume":"6","author":"YW Kim","year":"2011","unstructured":"Kim, Y. W., Grossmann, T. N. & Verdine, G. L. Synthesis of all-hydrocarbon stapled alpha-helical peptides by ring-closing olefin metathesis. Nat. Protoc. 6, 761\u2013771 (2011).","journal-title":"Nat. Protoc."},{"key":"41702_CR25","first-page":"331","volume":"49","author":"VS Guerlavais","year":"2014","unstructured":"Guerlavais, V. S., & Sawyer, T.K. Chapter Twenty-one\u2014advancements in stapled peptide drug discovery & development. Annu. Rep. Med. Chem. 49, 331\u2013345 (2014).","journal-title":"Annu. Rep. Med. Chem."},{"key":"41702_CR26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10930-018-9755-0","volume":"37","author":"D Migon","year":"2018","unstructured":"Migon, D., Neubauer, D. & Kamysz, W. Hydrocarbon stapled antimicrobial peptides. Protein J. 37, 2\u201312 (2018).","journal-title":"Protein J."},{"key":"41702_CR27","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.4049\/jimmunol.1403009","volume":"194","author":"FC Hansen","year":"2015","unstructured":"Hansen, F. C. et al. The thrombin-derived host defense peptide GKY25 inhibits endotoxin-induced responses through interactions with lipopolysaccharide and macrophages\/monocytes. J. Immunol. 194, 5397\u20135406 (2015).","journal-title":"J. Immunol."},{"key":"41702_CR28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1397-002x.2001.10994.x","volume":"59","author":"Y Chen","year":"2002","unstructured":"Chen, Y., Mant, C. T. & Hodges, R. S. Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic alpha-helix. J. Pept. Res. 59, 18\u201333 (2002).","journal-title":"J. Pept. Res."},{"key":"41702_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0021-9673(02)00356-4","volume":"972","author":"CT Mant","year":"2002","unstructured":"Mant, C. T. & Hodges, R. S. Reversed-phase liquid chromatography as a tool in the determination of the hydrophilicity\/hydrophobicity of amino acid side-chains at a ligand-receptor interface in the presence of different aqueous environments. II. Effect of varying peptide ligand hydrophobicity. J. Chromatogr. A 972, 61\u201375 (2002).","journal-title":"J. Chromatogr. A"},{"key":"41702_CR30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0021-9673(02)00354-0","volume":"972","author":"CT Mant","year":"2002","unstructured":"Mant, C. T. & Hodges, R. S. Reversed-phase liquid chromatography as a tool in the determination of the hydrophilicity\/hydrophobicity of amino acid side-chains at a ligand-receptor interface in the presence of different aqueous environments. I. Effect of varying receptor hydrophobicity. J. Chromatogr. A 972, 45\u201360 (2002).","journal-title":"J. Chromatogr. A"},{"key":"41702_CR31","first-page":"8","volume":"3","author":"NE Zhou","year":"1990","unstructured":"Zhou, N. E., Mant, C. T. & Hodges, R. S. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices. Pept. Res. 3, 8\u201320 (1990).","journal-title":"Pept. Res."},{"key":"41702_CR32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/jasms.0c00453","volume":"32","author":"BB Stocks","year":"2021","unstructured":"Stocks, B. B., Bird, G. H., Walensky, L. D. & Melanson, J. E. Characterizing Native and Hydrocarbon-Stapled Enfuvirtide Conformations with Ion Mobility Mass Spectrometry and Hydrogen-Deuterium Exchange. J. Am. Soc. Mass Spectrom. 32, 753\u2013761 (2021).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"41702_CR33","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1073\/pnas.0610494104","volume":"104","author":"CE Chang","year":"2007","unstructured":"Chang, C. E., Chen, W. & Gilson, M. K. Ligand configurational entropy and protein binding. Proc. Natl Acad. Sci. USA 104, 1534\u20131539 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41702_CR34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41592-019-0459-y","volume":"16","author":"GR Masson","year":"2019","unstructured":"Masson, G. R. et al. Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments. Nat. Methods 16, 595\u2013602 (2019).","journal-title":"Nat. Methods"},{"key":"41702_CR35","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.1202446","volume":"190","author":"SL Kelley","year":"2013","unstructured":"Kelley, S. L., Lukk, T., Nair, S. K. & Tapping, R. I. The crystal structure of human soluble CD14 reveals a bent solenoid with a hydrophobic amino-terminal pocket. J. Immunol. 190, 1304\u20131311 (2013).","journal-title":"J. Immunol."},{"key":"41702_CR36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.shk.0000191414.94461.7e","volume":"24","author":"WJ Hubbard","year":"2005","unstructured":"Hubbard, W. J. et al. Cecal ligation and puncture. Shock 24, 52\u201357 (2005).","journal-title":"Shock"},{"key":"41702_CR37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/089419301750420232","volume":"14","author":"H Freise","year":"2001","unstructured":"Freise, H., Bruckner, U. B. & Spiegel, H. U. Animal models of sepsis. J. Investig. Surg. 14, 195\u2013212 (2001).","journal-title":"J. Investig. Surg."},{"key":"41702_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31811-5","volume":"13","author":"H Ghaidan","year":"2022","unstructured":"Ghaidan, H. et al. Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation. Nat. Commun. 13, 4173 (2022).","journal-title":"Nat. Commun."},{"key":"41702_CR39","doi-asserted-by":"crossref","first-page":"L510","DOI":"10.1152\/ajplung.00524.2019","volume":"318","author":"M Stenlo","year":"2020","unstructured":"Stenlo, M. et al. Increased particle flow rate from airways precedes clinical signs of ARDS in a porcine model of LPS-induced acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 318, L510\u2013L517 (2020).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"41702_CR40","first-page":"2526","volume":"307","author":"ADT Force","year":"2012","unstructured":"Force, A. D. T. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526\u20132533 (2012).","journal-title":"JAMA"},{"key":"41702_CR41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrd3368","volume":"10","author":"R Macarron","year":"2011","unstructured":"Macarron, R. et al. Impact of high-throughput screening in biomedical research. Nat. Rev. Drug Discov. 10, 188\u2013195 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"41702_CR42","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1021\/jm050623t","volume":"48","author":"M Yamada","year":"2005","unstructured":"Yamada, M. et al. Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate. J. Med. Chem. 48, 7457\u20137467 (2005).","journal-title":"J. Med. Chem."},{"key":"41702_CR43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","volume":"584","author":"T Kawamoto","year":"2008","unstructured":"Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y. & Kimura, H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur. J. Pharm. 584, 40\u201348 (2008).","journal-title":"Eur. J. Pharm."},{"key":"41702_CR44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","volume":"79","author":"N Matsunaga","year":"2011","unstructured":"Matsunaga, N., Tsuchimori, N., Matsumoto, T. & Ii, M. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol. Pharm. 79, 34\u201341 (2011).","journal-title":"Mol. Pharm."},{"key":"41702_CR45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673\u2013683 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"41702_CR46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4062\/biomolther.2020.001","volume":"28","author":"AV Prakash","year":"2020","unstructured":"Prakash, A. V., Park, J. W., Seong, J. W. & Kang, T. J. Repositioned drugs for inflammatory diseases such as sepsis, asthma, and atopic dermatitis. Biomol. Ther. 28, 222\u2013229 (2020).","journal-title":"Biomol. Ther."},{"key":"41702_CR47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/biomedicines10040921","volume":"10","author":"I Rumienczyk","year":"2022","unstructured":"Rumienczyk, I., Kulecka, M., Statkiewicz, M., Ostrowski, J. & Mikula, M. Oncology drug repurposing for sepsis treatment. Biomedicines 10, 921 (2022).","journal-title":"Biomedicines"},{"key":"41702_CR48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/437942a","volume":"437","author":"S Frantz","year":"2005","unstructured":"Frantz, S. Drug discovery: playing dirty. Nature 437, 942\u2013943 (2005).","journal-title":"Nature"},{"key":"41702_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/ecp.12.74","volume":"6","author":"AS Reddy","year":"2013","unstructured":"Reddy, A. S. & Zhang, S. Polypharmacology: drug discovery for the future. Expert. Rev. Clin. Pharm. 6, 41\u201347 (2013).","journal-title":"Expert. Rev. Clin. Pharm."},{"key":"41702_CR50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.drudis.2008.02.001","volume":"13","author":"S Ohlson","year":"2008","unstructured":"Ohlson, S. Designing transient binding drugs: a new concept for drug discovery. Drug Discov. Today 13, 433\u2013439 (2008).","journal-title":"Drug Discov. Today"},{"key":"41702_CR51","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.str.2018.04.007","volume":"26","author":"RG Huber","year":"2018","unstructured":"Huber, R. G. et al. A thermodynamic funnel drives bacterial lipopolysaccharide transfer in the TLR4 pathway. Structure 26, 1151\u20131161 e1154 (2018).","journal-title":"Structure"},{"key":"41702_CR52","doi-asserted-by":"crossref","first-page":"14093","DOI":"10.1073\/pnas.1002713107","volume":"107","author":"GH Bird","year":"2010","unstructured":"Bird, G. H. et al. Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic. Proc. Natl Acad. Sci. USA 107, 14093\u201314098 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41702_CR53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bja.2018.05.072","volume":"121","author":"J Bauza-Martinez","year":"2018","unstructured":"Bauza-Martinez, J. et al. Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortality. Br. J. Anaesth. 121, 1065\u20131074 (2018).","journal-title":"Br. J. Anaesth."},{"key":"41702_CR54","doi-asserted-by":"crossref","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","volume":"295","author":"G Matute-Bello","year":"2008","unstructured":"Matute-Bello, G., Frevert, C. W. & Martin, T. R. Animal models of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L379\u2013L399 (2008).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"41702_CR55","doi-asserted-by":"crossref","unstructured":"Petruk, G., et al. SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity. J. Mol. Cell Biol. 12, 916\u2013932 (2020).","DOI":"10.1093\/jmcb\/mjaa067"},{"key":"41702_CR56","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/bi00731a008","volume":"12","author":"JD Morrisett","year":"1973","unstructured":"Morrisett, J. D., David, J. S., Pownall, H. J. & Gotto, A. M. Jr. Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry 12, 1290\u20131299 (1973).","journal-title":"Biochemistry"},{"key":"41702_CR57","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/biom10111572","volume":"10","author":"G Petruk","year":"2020","unstructured":"Petruk, G. et al. Concentration- and pH-dependent oligomerization of the thrombin-derived C-terminal peptide TCP-25. Biomolecules 10, 1572 (2020).","journal-title":"Biomolecules"},{"key":"41702_CR58","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/prot.20449","volume":"59","author":"WF Vranken","year":"2005","unstructured":"Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59, 687\u2013696 (2005).","journal-title":"Proteins"},{"key":"41702_CR59","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AW Sousa da Silva","year":"2012","unstructured":"Sousa da Silva, A. W. & Vranken, W. F. ACPYPE - AnteChamber PYthon Parser interfacE. BMC Res. Notes 5, 367 (2012).","journal-title":"BMC Res. Notes"},{"key":"41702_CR60","unstructured":"Abraham, M., van der Spoel, D., Lindahl, E. & Hess, B. GROMACS User Manual Version 5.0. 7. 2015. Search PubMed, 85-86."},{"key":"41702_CR61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"41702_CR62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov, D. et al. The ClusPro web server for protein-protein docking. Nat. Protoc. 12, 255\u2013278 (2017).","journal-title":"Nat. Protoc."},{"key":"41702_CR63","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"MY Shen","year":"2006","unstructured":"Shen, M. Y. & Sali, A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 15, 2507\u20132524 (2006).","journal-title":"Protein Sci."},{"key":"41702_CR64","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."},{"key":"41702_CR65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field. J. Chem. Theory Comput. 12, 405\u2013413 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"41702_CR66","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari, R., Kumar, R., Open Source Drug Discovery, C. & Lynn, A. g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model 54, 1951\u20131962 (2014).","journal-title":"J. Chem. Inf. Model"},{"key":"41702_CR67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"41702_CR68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello, G. et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44, 725\u2013738 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"41702_CR69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"41702_CR70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd1854","volume":"4","author":"JA Buras","year":"2005","unstructured":"Buras, J. A., Holzmann, B. & Sitkovsky, M. Animal models of sepsis: setting the stage. Nat. Rev. Drug Discov. 4, 854\u2013865 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"41702_CR71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch, D., Huber-Lang, M. S., Flierl, M. A. & Ward, P. A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4, 31\u201336 (2009).","journal-title":"Nat. Protoc."}],"updated-by":[{"DOI":"10.1038\/s41467-023-42294-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41702-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41702-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41702-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T22:08:19Z","timestamp":1700172499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41702-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41702"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-41702-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-023-42294-3","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-023-42294-3","URL":"https:\/\/doi.org\/10.1038\/s41467-023-42294-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A.S. is a founder of in2cure AB, a parent company of Xinnate AB, companies that are developing therapies based on thrombin-derived peptides and variants. G.P. is employed part-time (20%) by Xinnate AB. The TCP family, including stapled variants, is patent protected. Patent applicant: In2cure AB, Sweden. Inventors: Ganna Petruk, Artur Schmidtchen. Status of application: Publication Number: WO\/2023\/067167, Publication Date: 27.04.2023, International Application No.: PCT\/EP2022\/079429, International Filing Date: 21.10.2022. Specific aspect of manuscript covered in patent application: The invention relates to thrombin derived peptides comprising at least one internal covalent linkage between the side chains of two non-neighboring, internal amino acids. The peptides have anti-inflammatory effect. The sequences described herein are included in the patent application. The other authors declare no financial or non-financial conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6097"}}